Michel Pavic - Concepedia

Author

Michel Pavic

Centre Hospitalier Universitaire de Sherbrooke ORCID

Also Known As

Herlinde Dumez, Hervé Lévesque, M PAVIC, M Pavic, M. Pavic, M. Pavić, MICHEL PAVIC, Michel Pavic, Pavic Michel

217

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire de Sherbrooke Université de Sherbrooke Assistance Publique – Hôpitaux de Paris Dana-Farber Cancer Institute Harvard University

About

Michel Pavic is an author at Centre Hospitalier Universitaire de Sherbrooke specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.4K
2	Health Sciences	4	4	448
3	Exercise Physiology	2	2	44
4	Allergy	1	1	233
5	Gastroenterology	1	1	10

Michel Pavic

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer David Miles, Joseph Gligorov, Fabrice André, Annals of Oncology	2021	689
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study Michel Attal, Paul G. Richardson, S. Vincent Rajkumar, The Lancet Hematological MalignancyMedicineImmunologyHematologyPharmacotherapy	2019	620
CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients Laurent Arnaud, B. Hervier, A. Néel, Blood	2011	380
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial Paul G. Richardson, Albert Oriol, Meral Beksaç, The Lancet Oncology Hematological MalignancyMedicineHematologyMyeloid NeoplasiaPharmacotherapy	2019	375
IgG4-Related Systemic Disease Mikaël Ebbo, Laurent Daniel, Michel Pavic, Medicine ImmunodeficienciesImmunologyImmune RegulationPathologyElevated Igg4	2011	233
Late‐Onset Combined Immune Deficiency: A Subset of Common Variable Immunodeficiency with Severe T Cell Defect Marion Malphettes, Laurence Gérard, Maryvonnick Carmagnat, Clinical Infectious Diseases	2009	231
Retrospective study of intravascular large B-cell lymphoma cases diagnosed in Quebec Vanessa Brunet, Sofia Marouan, Jean‐Pierre Routy, Medicine	2017	102
Asteroids’ physical models from combined dense and sparse photometry and scaling of the YORP effect by the observed obliquity distribution J. Hanuš, Josef Ďurech, M. Brož, Astronomy and Astrophysics	2013	81
Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse Meletios Α. Dimopoulos, Katja Weisel, Philippe Moreau, Leukemia	2020	60
Exclusion of Patients with a Severe T-Cell Defect Improves the Definition of Common Variable Immunodeficiency Rémi Bertinchamp, Laurence Gérard, David Boutboul, The Journal of Allergy and Clinical Immunology In Practice Primary ImmunodeficiencyAutoimmune DiseaseHuman RetrovirusImmunologyHematology	2016	52

Page 1